Non-typhoid Salmonella: A review

Current Clinical Topics in Infectious Diseases

Volumn , Issue 20, 2000, Pages 134-157

  Fierer, Joshua ^a   Swancutt, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTEREMIA; CLASSIFICATION; GASTROENTERITIS; HUMAN; IMMUNOCOMPETENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; R FACTOR; REVIEW; SALMONELLA; SALMONELLOSIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MICROBIAL; GASTROENTERITIS; HUMANS; IMMUNOCOMPETENCE; R FACTORS; SALMONELLA; SALMONELLA INFECTIONS;

EID: 0034566136     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (202)

1. Le Minor L, Popoff MY. Request for an opinion. Designation of Salmonella enterica sp. nov., nom. rev., as the type and only species of the genus Salmonella. Int J Syst Bacteriol 1987;37:465-468.
2. Baumler AJ. The record of horizontal gene transfer in Salmonella. Trends Microbiol 1997;5:318-322.
3. Caillot O, Di Camillo P, Berche P, et al. Comparison of CHROMagar Salmonella medium and hektoen enteric agar for isolation of Salmonellae from stool samples. J Clin Microbiol 1999;37:762-765.
4. Perry JD, Ford M, Taylor J, et al. ABC medium, a new chromogenic agar for selective isolation of Salmonella spp. J Clin Microbiol 1999;37:766-768.
5. Tauxe RV. Emerging foodborne diseases: an evolving public health challenge. Emerg Infect Dis 1997;3:425-434.
6. Cruickshank JG. Salmonella special. Introduction. PHLS Microbiol Digest 1986;3:1-1.
7. Rhame FS, Root RK, MacLowry JD, et al. Salmonella septicemia from platelet transfusions. Study of an outbreak traced to a hematogenous carrier of Salmonella choleraesuis. Ann Intern Med 1973;78:633-641.
8. Stone EM. A waterborne epidemic of salmonellosis in Riverside, California, 1965. Epidemiologic aspects. A collaborative report. Am J Epidemiol 1971;93:33-48.
9. Lanser S, Motticc S, Nichols CR. Lizard-associated salmonellosis - Utah. MMWR 1992;41:610-612.
10. Rosenstein BJ, Russo P, Hinchliffe MC. A family outbreak of salmonellosis traced to a pet turtle. N Engl J Med 1965;272:960-961.
11. Williams LP Jr, Helsdon HL. Pet turtles as a cause of human salmonellosis. JAMA 1965;192:347-351.
12. Anonymous. Reptile-associated salmonellosis - selected states, 1994-1995. MMWR 1995;44:347-350.
13. Blaser MJ. How safe is our food? Lessons from an outbreak of salmonellosis. N Engl J Med 1996;334:1324-1325.
14. Craven PC, Baine WB, Mackel DC, et al. International outbreak of Salmonella eastbourne infection traced to contaminated chocolate. Lancet 1975;1:788-792.
15. Cook KA, Dobbs TE, Hlady WG, et al. Outbreak of Salmonella serotype Hartford infections associated with unpasteurized orange juice. JAMA 1998;280:1504-1509.
16. Anonymnous. Food handlers and salmonella food poisoning. Lancet 1987;2:606-607.
17. Hedberg CW, White KE, Johnson JA, et al. An outbreak of Salmonella enteritidis infection at a fast-food restaurant: implications for foodhandler-associated transmission. J Infect Dis 1991;164:1135-1140.
18. Riley LW, Cohen ML, Seals JE, et al. Importance of host factors in human salmonellosis caused by multiresistant strains of Salmonella. J Infect Dis 1984;149:878-883.
19. Louie KK, Paccagnella AM, Lior H, et al. Salmonella serotype Tennessee in powdered milk products and infant formula - Canada and United States, 1993. MMWR 1993;42: 516-517.
20. Van Bencden CA, Keene WE, Strang RA, et al. Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 1999; 281:158-162.
21. Mahon BE, Pönkä A, Hall WN, et al. An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds. J Infect Dis 1997;175: 876-882.
22. Ryan CA, Nickels MK, Hargrett-Bean NT, et al. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA 1987;258:3269-3274.
23. Hennessy TW, Hedberg CW, Slutsker L, et al. A national outbreak of Salmonella enteritidis infections from ice cream. N Engl J Med 1996;334:1281-1286.
24. Villar RG, Macek MD, Simons S, et al. Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washington state. JAMA 1999;281:1811-1816.
25. Cody SH, Abbott SL, Marfin AA, et al. Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in northern California. JAMA 1999;281:1805-1810.
26. Coyle EF, Ribeiro CD, Howard AJ, et al. Salmonella enteritidis phage type 4 infection: association with hens' eggs. Lancet 1988;2: 1295-1297.
27. Rampling A. Salmonella enteritidis five years on. Lancet 1993;342:317-318.
28. Mishu B, Koehler J, Lee LA, et al. Outbreaks of Salmonella enteritidis infections in the United States, 1985-1991. J Infect Dis 1994; 169:547-552.
29. Hargrett-Bean NT, Pavia AT, Tauxe RV. Salmonella isolates from humans in the United States, 1984-1986. MMWR CDC Surveill Summ 1988;37:25-31.
30. Keller LH, Benson CE, Krotec K, Eckroade RJ. Salmonella enteritidis colonization of the reproductive tract and forming and freshly laid eggs of chickens. Infect Immun 1995; 63:2443-2449.
31. Mishu B, Griffin PM, Tauxe RV, et al. Salmonella enteritidis gastroenteritis transmitted by intact chicken eggs. Ann Intern Med 1991; 115:190-194.
32. Humphrey TJ, Chapman PA, Rowe B, Gilbert RJ. A comparative study of the heat resistance of Salmonella in homogenized whole egg, egg yolk or albumen. Epidemiol Infect 1990;104:237-241.
33. Humphrey TJ, Greenwood M, Gilbert RJ, et al. The survival of Salmonella in shell eggs cooked under simulated domestic conditions. Epidem Infect 1989;103:35-45.
34. Hedberg CW, David MJ, White KE, et al. Role of egg consumption in sporadic Salmonella enteritidis and Salmonella typhimurium infections in Minnesota. J Infect Dis 1993; 167:107-111.
35. Glynn MK, Bopp C, Dewitt W, et al. Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States. N Engl J Med 1998;338:1333-1338.
36. Threlfall Ef, Ward LR, Rowe B. Multiresistant Salmonella typhimurium DT 104 and Salmonella bacteraemia. The Lancet 1998; 352:287-288.
37. Carattoli A, Tosini F, Visca P. Multidrug-resistant Salmonella enterica serotype typhimurium infections. N Engl J Med 1998; 339:921-922.
38. Rankin SC, Coyne MJ. Multiple antibiotic resistance in Salmonella enterica serotype enteritidis. The Lancet 1998;351:1740.
39. Holmberg SD, Wells JG, Cohen ML. Animal-to-man transmission of antimicrobial-resistant Salmonella: Investigations of U.S. outbreaks, 1971-1983. Science 1984;225: 833-835.
40. Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999;340:1525-1532.
41. Lin AW, Usera MA, Barrett TJ, Goldsby RA. Application of random amplified polymorphic DNA analysis to differentiate strains of Salmonella enteritidis. J Clin Microbiol 1996; 34:870-876.
42. Glynn JR, Palmer SR. Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak. Am J Epidemiol 1992;136:1369-1377.
43. Blaser MJ, Newman LS. A review of human salmonellosis: I. Infective dose. Rev Infect Dis 1982;4:1096-1106.
44. Guiney DG, Fang FC, Krause M, et al. Biology and clinical significance of virulence plasmids in Salmonella serovars. Clin Infect Dis 1995;21(suppl 2):S146-S151.
45. Lee CA, Falkow S. The ability of Salmonella to enter mammalian cells is affected by bacterial growth state. Proc Natl Acad Sci USA 1990;87:4304-4308.
46. McCormick BA, Colgan SP, Delp-Archer C, et al. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol 1993;123:895-907.
47. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993;61:4569-4574.
48. Day DW, Mandal BK, Morson BC. The rectal biopsy appearances in Salmonella colitis. Histopathology 1978;2:117-131.
49. Jones BD, Ghori N, Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 1994;180:15-23.
50. Wallis TS, Paulin SM, Plested JS, et al. The Salmonella dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis in cattle. Infect Immun 1995; 63:2755-2761.
51. McGovern VJ, Slavutin LJ. Pathology of Salmonella colitis. Am J Surg Pathol 1979;3: 483-490.
52. Bowe F, Lipps CJ, Tsolis RM, et al. At least four percent of the Salmonella typhimurium genome is required for fatal infection of mice. Infect Immun 1998;66:3372-3377.
53. Groisman EA, Ochman H. Pathogenicity islands: bacterial evolution in quantum leaps. Cell 1996;87:791-794.
54. Hueck CJ. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998;62:379-433.
55. Galán JE, Curtiss R III. Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. Proc Natl Acad Sci USA 1989;86:6383-6387.
56. Galán JE, Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999;284:1322-1328.
57. Chen L-M, Bagrodia S, Cerione RA, Galán JE. Requirement of p21-activated kinase (PAK) for Salmonella typhimurium-induced nuclear responses. J Exp Med 1999;189: 1479-1488.
58. Cirillo DM, Valdivia RH, Monack DM, Falkow S. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol Microbiol 1998; 30:175-188.
59. Ochman H, Soncini FC, Solomon F, Groisman EA. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc Natl Acad Sci USA 1996;93:7800-7804.
60. Uchiya K, Barbieri MA, Funato K, et al. A Salmonella virulence protein that inhibits cellular trafficking. EMBO J 1999;18:3924-3933.
61. Blanc-Potard AB, Groisman EA. The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival. EMBO J 1997;16:5376-5385.
62. Wong KK, McClelland M, Stillwell LC, et al. Identification and sequence analysis of a 27-kilobase chromosomal fragment containing a Salmonella pathogenicity island located at 92 minutes on the chromosome map of Salmonella enterica serovar typhimurium LT2. Infect Immun 1998;66:3365-3371.
63. Wood MW, Jones MA, Watson PR, et al. Identification of a pathogenicity island required for Salmonella enteropathogenicity. Mol Microbiol 1998;29:883-891.
64. Gulig PA, Danbara H, Guiney DG, et al. Molecular analysis of spy virulence genes of the Salmonella virulence plasmids. Mol Microbiol 1993;7:825-830.
65. Jones GW, Rabert DK, Svinarich DM, Whitfield HJ. Association of adhesive, invasive, and virulent phenotypes of Salmonella typhimurium with autonomous 60-megadalton plasmids. Infect Immun 1982;38: 476-486.
66. Chikami GK, Fierer J, Guiney DG. Plasmid-mediated virulence in Salmonella dublin demonstrated by use of a Tn5-orit construct. Infect Immun 1985;50:420-424.
67. Terakado N, Sekizaki T, Hashimoto K, Naitoh S. Correlation between the presence of a fifty-megadalton plasmid in Salmonella dublin and virulence for mice. Infect Immun 1983;41:443-444.
68. Roland KL, Martin LE, Esther CR, Spitznagel JK. Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence. J Bacteriol 1993;175: 4154-4164.
69. Abe A, Matsui H, Danbara H, et al. Regulation of spvR gene expression of Salmonella virulence plasmid pKDSC50 in Salmonella choleraesuis serovar Choleraesuis. Mol Microbiol 1994;12:779-787.
70. Barrow PA, Simpson JM, Lovell MA, Binns MM. Contribution of Salmonella gallinarum large plasmid toward virulence in fowl typhoid. Infect Immun 1987;55:388-392.
71. Barrow PA, Lovell MA. The association between a large molecular mass plasmid and virulence in a strain of Salmonella pullorum. J Gen Microbiol 1988;134:2307-2316.
72. Barrow PA. Immunity to experimental fowl typhoid in chickens induced by a virulence plasmid-cured derivative of Salmonella gallinarum. Infect Immun 1990;58:2283-2288.
73. Montenegro MA, Morelli G, Helmuth R. Heteroduplex analysis of Salmonella virulence plasmids and their prevalence in isolates of defined sources. Microb Pathog 1991;11:391-397.
74. Fang FC, Libby SJ, Buchmeier NA, et al. The alternative sigma factor KatF (RpoS) regulates Salmonella virulence. Proc Natl Acad Sci USA 1992;89:11978-11982.
75. Chen CY, Eckmann L, Libby SJ, et al. Expression of Salmonella typhimurium rpoS and rpoS-dependent genes in the intracellular environment of eukaryotic cells. Infect Immun 1996;64:4739-4743.
76. Roudier C, Krause M, Fierer J, Guiney DG. Correlation between the presence of sequences homologous to the vir region of Salmonella dublin plasmid pSDL2 and the virulence of twenty-two Salmonella serotypes in mice. Infect Immun 1990;58:1180-1185.
77. Groisman EA, Chiao E, Lipps CJ, Heffron F. Salmonella typhimurium phoP virulence gene is a transcriptional regulator. Proc Natl Acad Sci USA 1989;86:7077-7081.
78. Miller SI, Mekalanos JJ, Pulkkinen WS. Salmonella vaccines with mutations in the phoP virulence regulon. Res Microbiol 1990; 141:817-821.
79. 2+ as a regulatory signal. Bioessays 1998;20:96-101.
80. Groisman EA, Saier MH Jr. Salmonella virulence: new clues to intramacrophage survival. Trends Biochem Sci 1990;15:30-33.
81. Guo L, Lim KB, Gunn JS, et al. Regulation of lipid a modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997;276:250-253.
82. Brightbill HD, Libraty DH, Krutzik SR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285:732-736.
83. Mandell GL. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 1974;9:337-341.
84. van Dissel JT, Stikkelbroeck JJM, Sluiter W, et al. Differences in initial rate of intracellular killing of Salmonella typhimurium by granulocytes of Salmonella-susceptible C57BL/10 mice and Salmonella-resistant CBA mice. J Immunol 1986;136:1074-1080.
85. Steigbigel RT, Lambert LH, Remington JS. Phagocytic and bactericidal properties of normal human monocytes. J Clin Invest 1974;53:131-142.
86. De Groote MA, Ochsner UA, Shiloh MU, et al. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci USA 1997;94:13997-14001.
87. Lundberg BE, Wolf RE Jr, Dinauer MC, et al. Glucose 6-phosphate dehydrogenase is required for Salmonella typhimurium virulence and resistance to reactive oxygen and nitrogen intermediates. Infect Immun 1999; 67:436-438.
88. Vassiloyanakopoulos AP, Okamoto S, Fierer J. The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. PNAS 1998;95:7676-7681.
89. Fields PI, Swanson RV, Haidaris CG, Heffron F. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci USA 1986;83:5189-5193.
90. Fang FC. NO contest: nitric oxide plays complex roles in infection. The impish NO and several close chemical relatives sometimes combat, other times assist a wide range of pathogens. ASM News 1997;63:668-673.
91. De Groote MA, Testerman T, Xu Y, et al. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 1996;272:414-417.
92. Shiloh MU, Ruan J, Nathan C. Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infect Immun 1997;65:3193-3198.
93. Plant J, Glynn AA. Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis 1976;133:72-78.
94. Govoni G, Vidai S, Cellier M, et al. Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics 1995;27:9-19.
95. 2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. J Exp Med 1994;179:1683-1687.
96. Vidai SM, Malo D, Vogan K, et al. Natural resistance to infection with intracellular parasites: isolation of a candidate for Beg. Cell 1993;73:469-485.
97. Bellamy R, Ruwende C, Corrah T, et al. Variations in the NRANIP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-644.
98. Cellier M, Prive G, Belouchi A, et al. Nramp defines a family of membrane proteins. Proc Natl Acad Sci USA 1995;92: 10089-10093.
99. Holland SM. Stimulating the phagocytes: progress and problems (editorial). J Med Microbiol 1999;48:111-112.
100. van Dissel JT, Stikkelbroeck JM, Michel BC, et al. Inability of recoinbinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol 1987;139:1673-1678.
101. Langermans JA, Nibbering PH, van der Hulst ME, van Furth R. Microbicidal activities of Salmonella typhimurium- and interferon-gamma-activated mouse peritoneal macrophages. Pathobiology 1991;59:189-193.
102. Langermans JA, van der Hulst MEB, Nibbering PH, van Furth R. Activation of mouse peritoneal macrophages during infection with Salmonella typhimurium does not result in enhanced intracellular killing. J Immunol 1990;144:4340-4346.
103. Kumazawa Y, Fruedenberg MA, Hausmann C, et al. Formation of interferon-gamma and tumor necrosis factor in mice during Salmonella typhimurium infection. Pathobiology 1991;59:194-196.
104. s) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J Immunol 1996;156: 2894-2900.
105. O'Brien AD, Weinstein DA, Soliman MY, Rosenstreich DL. Additional evidence that the LPS gene locus regulates natural resistance to S. typhimurium in mice. J Immunol 1985;134:2820-2823.
106. Matsumura H, Onozuka K, Terada Y, et al. Effect of murine recombinant interferon-gamma in the protection of mice against Salmonella. Int J Immunopharmacol 1990; 12:49-56.
107. Mastroeni P, Skepper JN, Hormaeche CE. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect Immun 1995;63: 3674-3682.
108. Muotiala A, Makala PH. The role of IFN-gamma in murine Salmonella typhimurium infection. Microb Pathog 1990;8:135-141.
109. Nauciel C, Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun 1992; 60:450-454.
110. Tite JP, Dougan G, Chatfield SN. The involvement of tumor necrosis factor in immunity to Salmonella infection. J Immunol 1991;147:3161-3164.
111. Everest P, Allen J, Papakonstantinopoulou A, et al. Salmonella typhimurium infections in mice deficient in interleukin-4 production. Role of IL-4 in infection-associated pathology. J Immunol 1997;159:1820-1827.
112. Arai T, Hiromatsu K, Nishimura H, et al. Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection. Immunology 1995;85:381-388.
113. Mastroeni P, Harrison JA, Robinson JH, et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 1998;66:4767-4776.
114. Ottenhoff THM, Kumarararne D, Casanova J-L. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol. Today 1998;19:491-494.
115. de Jong R, Altare F, Haagen I-A, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998;280:1435-1438.
116. Pai SR, Upshaw Y, Singh SP. Characterization of monoclonal antibodies to the outer membrane protein (OmpD) of Salmonella typhimurium. Can J Microbiol 1992;38: 1102-1107.
117. Carlin NIA, Svenson SB, Lindberg AA. Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb Pathog 1987;2:171-183.
118. Plotkin SA, Bouveret-Le Cam N. A new typhoid vaccine composed of the Vi capsular polysaccharide. Arch Intern Med 1995;155: 2293-2299.
119. + TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol 1996;156: 3321-3326.
120. Cookson BT, Bevan MJ. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J Immunol 1997;158:4310-4319.
121. Hoiseth SK, Stocker BAD. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981;291:238-239.
122. Hormaeche CE, Joysey HS, Desilva L, et al. Immunity induced by live attenuated Salmonella vaccines. Res. Microbiol. 1990; 141:757-764.
123. Fierer J, Chikami G, Hatlen L, et al. Active immunization with LD842, a plasmidcured strain of Salmonella dublin, protects mice against group D and group B Salmonella infection. J Infect Dis 1988;158:460-463.
124. Lindberg AA, Segall T, Weintraub A, Stocker BAD. Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA 04-09 hybrid Salmonella dublin strain. Infect Immun 1993;61:1211-1221.
125. Saphra I, Winter JW. Clinical manifestations of salmonellosis in man. An evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med 1957;256:1128-1134.
126. Garcia-Corbeira P, Ramos JM, Aguado JM, Soriano F. Six cases in which mesenteric lymphadenitis due to non-typhi Salmonella caused an appendicitis-like syndrome. Clin Infect Dis 1995;21:231-232.
127. Hook EW. Salmonellosis: certain factors influencing the interaction of Salmonella and the human host. Bull NY Acad Med 1961;37:499-512.
128. Pavia AT, Shipman LD, Wells JG, et al. Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. J Infect Dis 1990;161:255-260.
129. Williams RD, Rollins LD, Pocurull DW, et al. Effect of feeding chlortetracycline on the reservoir of Salmonella typhimurium in experimentally infected swine. Antimicrob Agents Chemother 1978;14:710-719.
130. Lester A, Eriksen NHR, Nielsen H, et al. Non-typhoid Salmonella bacteraemia in greater Copenhagen 1984 to 1988. Eur J Clin Microbiol Infect Dis 1991;10:486-490.
131. Blaser MJ, Feldman RA. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis 1981;143: 743-746.
132. Fierer J, Krause M, Tauxe R, Guiney D. Salmonella typhimurium bacteremia: association with the virulence plasmid. J Infect Dis 1992;166:639-642.
133. Helmuth R, Stephan R, Bunge C, et al. Epidemiology of virulence-associated plasmids and outer membrane protein patterns within seven common Salmonella serotypes. Infect Immun 1985;48:175-182.
134. Cherubin CE, Fodor T, Denmark LI, et al. Symptoms, septicemia and death in salmonellosis. Am J Epidemiol 1969;90:285-291.
135. Goldberg MB, Rubin RH. The spectrum of Salmonella infection. Infect Dis Clin North Am 1988;2:571-598.
136. Saphra I, Wassermann M. Salmonella cholerae suis. A clinical and epidemiological evaluation of 329 infections identified between 1940 and 1954 in the New York Salmonella center. Am J Med Sci 1954;228: 525-533.
137. Heineman HS, Jensen WN, Cooper WM, Braude AI. Hodgkin's disease and Salmonella typhimurium infection. JAMA 1964;188:632-634.
138. Fischl MA, Dickinson GM, Sinave C, et al. Salmonella bacteremia as manifestation of acquired immunodeficiency syndrome. Arch Intern Med (Chicago) 1986;146:113-115.
139. Han T, Sokal JE, Neter E. Salmonellosis in disseminated malignant diseases. A seven-year review (1959-1965). N Engl J Med 1967;276: 1045-1052.
140. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280:1432-1435.
141. Kaye D, Gill FA, Hook EW. Factors influencing host resistance to Salmonella infections: the effects of hemolysis and erythrophagocytosis. Am J Med Sci 1967;254: 205-215.
142. Mouy R, Fischer A, Vilmer E, et al. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989;114:555-560.
143. Manicourt DH, Orloff S. Immune complexes in polyarthritis after Salmonella gastroenteritis. J Rheumatol 1981;8:613-620.
144. Wang J-H, Liu Y-C, Yen M-Y, et al. Mycotic aneurysm due to non-typhi Salmonella: report of 16 cases. Clin Infect Dis 1996;23:743-747.
145. Chan P, Tsai CW, Huang JJ, et al. Salmonellosis and mycotic aneurysm of the aorta. A report of 10 cases. J Infect 1995;30:129-133.
146. Cohen PS, O'Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection adults with Salmonella bacteremia. Ann Intern Med 1978;89:931-932.
147. Schneider PJ, Nernoff J III, Gold JA. Acute Salmonella endocarditis. Report of a case and review. Arch Intern Med 1967;120:478-486.
148. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine 1971;50:97-112.
149. Anand AJ, Glatt AE. Salmonella osteomyelitis and arthritis in sickle cell disease. Semin Arthritis Rheum 1994;24:211-221.
150. Cohen JI, Bartlett JA, Corey GR. Extraintestinal manifestations of Salmonella infections. Medicine 1987;66:349-388.
151. Kauffman CA, St. Hilaire RJ. Salmonella meningitis. Occurrence in an adult. Arch Neurol 1979;36:578-580.
152. Rodriguez RE, Valero V, Watanakunakorn C. Salmonella focal intracranial infections: review of the world literature (1884-1984) and report of an unusual case. Rev Infect Dis 1986;8:31-41.
153. Kinsella TR, Yogev R, Shulman ST, et al. Treatment of Salmonella meningitis and brain abscess with the new cephalosporins: two case reports and a review of the literature. Pediatr Infect Dis J 1987;6:476-480.
154. Chin C-H, Ou JT. Persistence of Salmonella species in cerebrospinal fluid of patients with meningitis following ceftriaxone therapy. Clin Infect Dis 1999;28:1174-1175.
155. West SE, Goodkin R, Kaplan AM. Neonatal Salmonella meningitis complicated by cerebral abscesses. West J Med 1977;127: 142-145.
156. Hathout SED, El-Ghaffar YA, Awny AY, Hassan K. Relation between urinary schistosomiasis and chronic enteric urinary carrier state among Egyptians. Am J Trop Med Hyg 1966;15:156-161.
157. Ramos JM, Aguado JM, Garcia-Corbeira P, et al. Clinical spectrum of urinary tract infections due to nontyphoidal Salmonella species. Clin Infect Dis 1996;23:388-390.
158. Scott MB, Cosgrove MD. Salmonella infection and the genitourinary system. J Urol 1977;118:64-68.
159. Wilson R, Feldman RA. Salmonella isolates from urine in the United States, 1968-1979. J Infect Dis 1982;146:293-296.
160. Wolfe MS, Louria DB, Armstrong D, Blevins A. Salmonellosis in patients with neoplastic disease. A review of 100 episodes at Memorial Cancer Center over a 13-year period. Arch Intern Med 1971;128:546-554.
161. Celum CL, Chaisson RE, Rutherford GW, et al. Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987;156:998-1002.
162. Sperber SJ, Schleupner CJ. Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis 1987;9:925-934.
163. Gilks CF. Acute bacterial infections and HIV disease. Br Med Bull 1998;54:383-393.
164. Gilks CF, Brindle RJ, Otieno LS, et al. Lifethreatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990;336:545-549.
165. Gruenewald R, Blum S, Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infect Dis 1994;18:358-363.
166. Fraimow HS, Wormser GP, Coburn KD, Small CB. Salmonella meningitis and infection with HIV. AIDS 1990;4:1271-1273.
167. Aliaga L, Mediavilla JD, López de la Osa A, et al. Nontyphoidal Salmonella intracranial infections in HIV-infected patients. Clin Infect Dis 1997;25:1118-1120.
168. Mayer KH, Hanson E. Recurrent Salmonella infection with a single strain in the acquired immunodeficiency syndrome. Confirmation by plasmid fingerprinting. Diag Microbiol Infect Dis 1986;4:71-76.
169. Jacobson MA, Hahn SM, Gerberding JL, et al. Ciprofloxacin for Salmonella bacteremia in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110:1027-1029.
170. Neves J, Martins NR. Long duration of septicaemic salmonellosis: 35 cases with 12 implicated species of Salmonella. Trans R Soc Trop Med Hyg 1967;61:541-552.
171. Gendrel D, Kombila M, Beaudoin-Leblevec G, Richard-Lenoble D. Nontyphoidal Salmonellal septicemia in Gabonese children infected with Schistosoma intercalatum. Clin Infect Dis 1994;18:103-105.
172. Rocha H, Kirk JW, Hearey CD. Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection. Arch Intern Med 1971;128:254-257.
173. Melhem RF, LoVerde PT. Mechanism of interaction of Salmonella and Schistosoma species. Infect Immun 1984;44:274-281.
174. Jertborn M, Haglind P, Iwarson S, Svennerholm A-M. Estimation of symptomatic and asymptomatic Salmonella infections. Scand J Infect Dis 1990;22:451-455.
175. Balfour AE, Lewis R, Ahmed S. Convalescent excretion of Salmonella enteritidis in infants. J Infect 1999;38:24-25.
176. Buchwald DS, Blaser MJ. A review of human salmonellosis: H. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis 1984;6:345-356.
177. Fierer J, Hatlen L, Lin J-P, et al. Successful treatment using gentamicin liposomes of Salmonella dublin infections in mice. Antimicrob Agents Chemother 1990;34:343-348.
178. Lee LA, Puhr ND, Maloney EK, et al. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis 1994;170:128-134.
179. Herikstad H, Hayes P, Mokhtar M, et al. Emerging quinolone-resistant Salmonella in the United States. Emerg Infect Dis 1997; 3:371-372.
180. Tzouvelekis LS, Gazouli M, Markogiannakis A, et al. Emergence of resistance to third-generation cephalosporins amongst Salmonella typhimurium isolates in Greece: report of the first three cases. J Antimicrob Chemother 1998;42:273-275.
181. Aserkoff B, Bennett JV. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med 1969;281:636-040.
182. Sánchez C, García-Restoy E, Garau J, et al. Ciprofloxacin and trimethoprimsulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. J Infect Dis 1993;168: 1304-1307.
183. Neill MA, Opal SM, Heelan J, et al. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. Ann Intern Med 1991;114:195-199.
184. Carlstedt G, Dahl P, Niklasson PM, et al. Norfloxacin treatment of salmonellosis does not shorten the carrier stage. Scand J Infect Dis 1990;22:556.
185. Akalin HE. Quinolones in the treatment of acute bacterial diarrhoeal diseases. Drugs 1993;45(suppl 3):114-118.
186. Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med 1992;117: 727-734.
187. Thuluvath PJ, McKendrick MW. Salmonella and complications related to age - Sheffield experience. Qtly J Med 1988;67: 497-503.
188. Meerkin D, Yinnon AM, Munter RG, et al. Salmonella mycotic aneurysm of the aortic arch: case report and review. Clin Infect Dis 1995;21:523-528.
189. Bryan JP, Rocha H, Scheld WM. Problems in salmonellosis: rationale for clinical trials with newer β-lactam agents and quinolones. Rev Infect Dis 1986;8:189-207.
190. Hormaeche CE, Joysey HS, Desilva L, et al. Immunity conferred by Aro- Salmonella live vaccines. Microb Pathog 1991;10:149-158.
191. Fukushima N, Ishikawa N, Shimazaki Y, et al. Salmonella prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1996;112: 840-842.
192. Goerre S, Malinverni R, Aeschbacher BC. Successful conservative treatment of non-typhoid Salmonella endocarditis involving a bioprosthetic valve. Clin Cardiol 1998;21: 368-370.
193. Kavaliotis J, Tsiaousi A, Papavasiliou D, Kansouzidou A. Non-typhoid Salmonella meningitis. Scand J Infect Dis 1994;26:403-405.
194. Headrick ML, Korangy S, Bean NH, et al. The epidemiology of raw milk-associated foodborne disease outbreaks reported in the United States, 1973 through 1992. Am J Public Health 1998;88:1219-1221.
195. Chin J. Raw milk: a continuing vehicle for the transmission of infectious disease agents in the United States. J Infect Dis 1982;146:440-441.
196. Noskin GA, Clarke JT. Salmonella arizonae bacteremia as the presenting manifestation of human immunodeficiency virus infection following rattlesnake meat ingestion. Rev Infect Dis 1990;12:514-517.
197. Casado JL, Valdezate S, Calderon C, et al. Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. J Infect Dis 1999;179:1553-1556.
198. Fierer J. Invasive Salmonella dublin infections associated with drinking raw milk. West J Med 1983;138:665-669.
199. Tacket CO, Dominguez LB, Fisher HJ, Cohen ML. An outbreak of multipledrug-resistant Salmonella enteritis from raw milk. JAMA 1985;253:2058-2060.
200. Werner SB, Humphrey GL, Kamei I. Association between raw milk and human Salmonella dublin infection. Br Med J 1979; 2:238-241.
201. Telzak EE, Budnick LD, Greenberg MSZ, et al. A nosocomial outbreak of Salmonella enteritidis infection due to the consumption of raw eggs. N Engl J Med 1990;323:394-397.
202. Schroeder SA, Aserkoff B, Brachman PS. Epidemic salmonellosis in hospitals and institutions. A five-year review. N Engl J Med 1968;279:674-678.